Katoo Muylle

7PUBLICATIONS
15CO-AUTHORS
Haematological tumoursCancer cell biologyNanotoxicology, health and safetyReinforcement learningToxicology (incl. clinical toxicology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Mar 18, 2026
Leveraging Digital Technology and Artificial Intelligence to Describe the Real-World Belgian Chronic Lymphocytic Leukemia Patient Population: The BE-CLLEAR Study.

Matthias Vanderkerken, Koen Van Eygen, Veerle Galle

|Jan 08, 2026
Real-life data on clinical characteristics, treatments and outcomes of patients with newly diagnosed advanced-stage ovarian cancer: an observational study from Belgium.

Els Van Nieuwenhuysen, Stephanie Henry, Katoo Muylle

|Dec 02, 2024
Clinical Decision Support and New Regulatory Frameworks for Medical Devices: Are We There Yet? A Response to the Recent Commentaries.

Katoo M Muylle, Audrey Van Scharen, Veronique Shiwa

|Nov 23, 2022
Machine Learning Techniques Outperform Conventional Statistical Methods in the Prediction of High Risk QTc Prolongation Related to a Drug-Drug Interaction.

Sven Van Laere, Katoo M Muylle, Alain G Dupont

|Nov 02, 2022
Added value of patient- and drug-related factors to stratify drug-drug interaction alerts for risk of QT prolongation: Development and validation of a risk prediction model.

Katoo M Muylle, Sven van Laere, Luigi Pannone

|Apr 13, 2022
Physicians' needs for drug allergy documentation in electronic health records and allergy alert systems: Results of an end user's survey.

Katoo M Muylle, Sven Van Laere, Martine Grosber

Pageof 2

Frequent Collaborators

5 joint publications

Pieter Cornu

3 joint publications

Sven Van Laere

1 joint publications

Martine Grosber

1 joint publications

Alain G Dupont